Desethylhydroxychloroquine for the treatment of diseases associated with inflammation
Abstract:
Compositions and methods are provided for inhibiting or treating the early and established stages of inflammatory diseases by administration of an effective dose of the desethylhydroxychloroquine (DHCQ). A benefit of the methods is the ability to deliver a dose of agent that is effective in treating inflammation while sparing the individual from retinal toxicity.
Information query
Patent Agency Ranking
0/0